Bioorganic and Medicinal Chemistry Letters p. 1077 - 1082 (1998)
Update date:2022-08-02
Topics:
Patel, Mona
Kaltenbach III, Robert F.
Nugiel, David A.
McHugh Jr., Robert J.
Jadhav, Prabhakar K.
Bacheler, Lee T.
Cordova, Beverly C.
Klabe, Ronald M.
Erickson-Viitanen, Susan
Garber, Sena
Reid, Carol
Seitz, Steven P.
Cyclic urea SD 146, a potent HIV protease inhibitor bearing a flat resistance profile, possessed poor solubility and bioavailability, which precluded further development of the compound. In an effort to improve upon the pharmacokinetic profile of the compound, several analogs modified at the P1/P1' residues were prepared and evaluated. Several of those compounds displayed significant improvement of physical properties.
View MoreContact:+86-838-5655598
Address:Guanghan Nanfeng Industrial Zone
Contact:86-571-87758773
Address:Room604 ,6F, Block A1-3 Xixi Plaza,No. 588 Wenyi West RD, Hangzhou,310012, China
Shanghai Sunway Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-5161 3915
Address:Shanghai YangPu
Shanghai Send Pharmaceutical Technology Co., Ltd.
website:http://www.shsendpharma.com
Contact:021-58088081, +8613585868794
Address::Room A601, Building 1,NO. 800 Qingdai Road Pudong District Shanghai,China
website:http://www.apeptides.com/en/
Contact:+86-21-60871011
Address:No. 80 Chuanshan Shuyuan Steet,Pudong,Shanghai
Doi:10.1039/C1968001400b
(1968)Doi:10.1021/ic50022a024
(1964)Doi:10.1021/om980222u
(1998)Doi:10.1021/jp981158x
(1998)Doi:10.1021/jo0478609
(2005)Doi:10.1021/ja01464a040
(1961)
